ASIA PRIMARY ANGIOPLASTY CONGRESS 2025
Keeping the AMI Passion Alive!
25-26 July 2025
Bali, Indonesia
25 – 26 July 2025
The Meru Sanur, Bali Beach Convention Centre
Bali, Indonesia
It’s a wrap.
Total participants : 523 domestic + 111 international = 634
Faculty : 🇸🇬🇲🇾🇻🇳🇧🇩🇹🇼🇧🇳🇯🇵🇹🇭🇵🇭🇭🇰
Scientific : 18 scientific session + 6 GP session + 12 case parades + 67 oral presentation + 15 meta analysis and original research + 52 case reports + 4 best case Chien Foundation
Program : Scientific Session + AMI Jeopardy + Sanur Sunrise Run + Tennis Gathering + Faculty dinner.
The Indonesian ACS Summit in conjunction with the Asia Primary Angioplasty Congress (APAC) left a lasting impression on the participants. It was a congress not only for sharing knowledge across countries, but also for strengthening collaboration and building meaningful connections.
See you APAC 2026 in Singapore!
Course Directors
Singapore Faculty
Programme
Program at a glance
Friday, 25 July 2025
Ballroom 1: STEMI Track
Sesi 1 – Pre & Hospital of STEMI Care
Chairman: Ho Hee Hwa | Co-Chairman: Saifur Rohman
Panelist: Kwan Lee, Chun Yao Huang, Isman Firdaus
Panelist: Kwan Lee, Chun Yao Huang, Isman Firdaus
08.30 – 08.42
Early STEMI Management: The Critical Role of Prehospital Care
Saifur Rohman
08.42 – 08.54
Precision Thrombolysis: Aligning Clinical Benefit and Safety
Isman Firdaus
08.54 – 09.06
Anticoagulant Strategies in PPCI and Post-Thrombolysis: Timing, Selection, and Risk Management
I Kadek Susila Surya Darma
09.06 – 09.18
Detecting Occlusion Myocardial Infarction: A Step Toward Faster Reperfusion
Kwan Lee
09.18 – 09.30
Discussion
Sesi 3 – Antithrombotic strategy in Primary PCI
Chairman: Koh Tian Hai | Co-Chairman: Sidney Lo
Panelist: Yu Chen Wang, Miftah Pramudyo, Hakim Alkatiri, David Huang, Faisal Habib
Panelist: Yu Chen Wang, Miftah Pramudyo, Hakim Alkatiri, David Huang, Faisal Habib
09.30 – 09.42
Better understanding of thrombus burden in STEMI: thinking inside the coronaries
Hakim Alkatiri
09.42 – 09.54
From DAPT to De-escalation: Rethinking Antiplatelet Therapy in High-Bleeding-Risk STEMI
David Huang
09.54 – 10.06
From Trial to Practice: Reduced dose Prasugrel Insights from the PROMISE-TW Registry
Yu Chen Wang
10.06 – 10.18
The role of GP IIb/IIIa inhibitors in primary PCI and early percutaneous coronary intervention
Miftah Pramudyo
10.18 – 10.30
Discussion
Ballroom 2: NSTEMI Track
Sesi 2 – Antiplatelets for pretreatment
Chairman: David Huang | Co-Chairman: Jason Loh KK
Panelist: M. Yusuf Alsagaff, Budi Yuli Setianto, Dinh Duc Huy, Safir Sungkar
Panelist: M. Yusuf Alsagaff, Budi Yuli Setianto, Dinh Duc Huy, Safir Sungkar
08.30 – 08.42
The Evolving Role of P2Y12 Inhibitors in Early NSTEMI Management
Budi Yuli Setianto
08.42 – 08.54
Antiplatelet pre-treatment: The Choice, Timing, and The Impact
Dinh Duc Huy
08.54 – 09.06
Truncated DAPT in ACS: Are We Ready to Cut It Short?
Fahim Jafary
09.06 – 09.18
Should we adopt the recommended guidelines? (insight from One ACS registry)
Safir Sungkar
09.18 – 09.30
Discussion
Sesi 4 – Invasive strategy
Chairman: Amir Aziz Alkatiri | Co-Chairman: Dinh Duc Huy
Panelist: Goh Yew Seong, Bambang Widyantoro, Chun Yao Huang
Panelist: Goh Yew Seong, Bambang Widyantoro, Chun Yao Huang
09.30 – 09.42
Balancing Risk and Reward: How Early Should We Intervene in ACS?
Ismir Fahri
09.42 – 09.54
Invasive Strategy in Elderly AMI Patients: A Necessity or a Risky Gamble?
Goh Yew Seong
09.54 – 10.06
Should Non-Culprit Lesions Be Treated in Early Invasive Strategy for ACS?
Fahim Jafary
10.06 – 10.18
Minimizing Risk: Prevention and Management of Iatrogenic Coronary Dissection to Avert Myocardial Infarction
Ching-Tang Chang
10.18 – 10.30
Discussion
10.30 – 11.00 Opening Ceremony
Sesi 5 – Choice of balloon or stent treatment in PPCI
Chairman: Doni Firman | Co-Chairman: Paul Ong
Panelist: Al Fazir Omar, Amir Aziz Alkatiri, Teguh Santoso
Panelist: Al Fazir Omar, Amir Aziz Alkatiri, Teguh Santoso
11.00 – 11.12
Complete or Culprit-only PCI in patients with STEMI: an update
Teguh Santoso
11.12 – 11.24
Drug-Coated Balloons for IRA in ACS: A Promising Strategy When Stenting Is Not an Option
Amir Aziz Alkatiri
11.24 – 11.36
When to use DCB in STEMI?
Ho Hee Hwa
11.36 – 11.48
The choice of DCB in Acute Myocardial Infarction
Jose Nicolas Cruz
11.48 – 12.00
Discussion
Sesi 6 – A to Z: Comprehensive Strategies for Optimizing Acute Coronary Syndrome Outcomes
Chairman: A. Fauzi Yahya | Co-Chairman: Dafsah Arifa Juzar
Panelist: I Made Junior Rina Artha, I Kadek Susila Surya Darma, Hendy Wirawan
Panelist: I Made Junior Rina Artha, I Kadek Susila Surya Darma, Hendy Wirawan
11.00 – 11.18
Optimizing Potent Antiplatelet Therapy in Contemporary ACS: A Simple Approach for Most Patients
Sunanto Ng
11.18 – 11.36
High-Intensity Statins in ACS: Navigating Standards in Cardiovascular Outcomes
Rony Santoso
11.36 – 11.48
Evolution of Sleep Apnea Phenotypes in ACS and Impact on Treatment
Ronald Lee
11.48 – 12.00
Discussion
12.00 – 13.00 Lunch, Friday Prayer, and Exhibition
Sesi 7 – Role of imaging & physiology
Chairman: M. Munawar | Co-Chairman: Fujita Tsutomu
Panelist: Lim Ing Haan, Amir Aziz Alkatiri, Rajinikanth Rajagopal
Panelist: Lim Ing Haan, Amir Aziz Alkatiri, Rajinikanth Rajagopal
13.00 – 13.12
Intravascular Imaging in ACS Revascularization: The Key to Better Long-Term Outcomes
Amir Aziz Alkatiri
13.12 – 13.24
The Impact of Intravascular Imaging on PCI Decision-Making in AMI
Rajinikanth Rajagopal
13.24 – 13.36
FFR-Guided vs. Angiography-Guided Management in NSTE-ACS: Which Leads to Better Outcomes?
Nikolas Wanahita
13.36 – 13.48
Nightmares in the Cath Lab: Managing Catastrophic PCI Complications in ACS with Imaging and Physiology-Guided Strategies
Pannipa Suwannasom
13.48 – 14.00
Discussion
Sesi 9 – Coronary Intervention in patients with out of hospital cardiac arrest (OHCA)
Chairman: Asri Ranga | Co-Chairman: Jack Tan
Panelist: Vienna Rossimarina, Chun Yao Huang, Siska Suridanda Danny
Panelist: Vienna Rossimarina, Chun Yao Huang, Siska Suridanda Danny
14.00 – 14.12
Balancing Risks and Benefits: Primary PCI in Delayed STEMI Patients with OHCA
Yudi Her Oktaviono
14.12 – 14.24
Immediate Invasive Strategies vs. Conservative Management in OHCA with NSTEMI: What’s the Best Approach?
Siska Suridanda Danny
14.24 – 14.36
Emerging Strategies in eCPR and Coronary Intervention for OHCA Patients
Jack Tan
14.36 – 14.48
Long-Term Outcomes and Post-PCI Recovery in OHCA Survivors: Cardiac, Neurological, and Rehabilitation Considerations
Chun Yao Huang
14.48 – 15.00
Discussion
Sesi 11 – Emerging therapies for interventional thrombus modification in STEMI
Chairman: Doni Firman | Co-Chairman: Jack Tan
Panelist: Isman Firdaus, Ho Hee Hwa, Indah Sukmawati
Panelist: Isman Firdaus, Ho Hee Hwa, Indah Sukmawati
15.00 – 15.12
Emerging therapies for interventional thrombus modification in STEMI
Yuji Ikari
15.12 – 15.24
STEMI with massive thrombus burden: how should I treat?
I Made Junior Rina Artha
15.24 – 15.36
Utility Pharmaco-mechanical thrombus aspiration in STEMI patients with high thrombotic burden
Jason Loh KK
15.36 – 15.48
No re-flow in STEMI prevention and how to deal with?
Lim Ing Haan
15.48 – 16.00
Discussion
Sesi 8 – Best Case Presentation (Chien Foundation, Singapore)
Chairman: Richard Ng | Co-Chairman: Sunarya Soerianata
Jury: Asri Ranga, Chun Yao Huang, Sodiqur Rifqi, Dafsah Arifa Juzar, Doni Firman, Paul Ong
Jury: Asri Ranga, Chun Yao Huang, Sodiqur Rifqi, Dafsah Arifa Juzar, Doni Firman, Paul Ong
13.00 – 13.12
Complete Multi Culprits Revascularization in Acute Coronary Syndrome: A Case Report
Presenter: Yusuf Azmi
13.12 – 13.24
Aortic Valve Infective Endocarditis Presenting as Myocardial Infarction and Embolic Stroke: A Case Report
Presenter: Cornelia Ghea Savitri
13.24 – 13.36
A Double Jeopardy in CTO Revascularization Stent Thrombosis and Pericardial Tamponade from Angiographically Silent Coronary Perforation
Presenter: Fransiska Anggreni Sihotang
13.36 – 13.48
Microaxial flow Pump On Top Of Atrial Septostomy For Lv Decompression Strategy In Ecmo-supported Myocardial Infarction Cardiogenic Shock A Case Report
Presenter: Suryo Ardi Hutomo
13.48 – 14.00
Discussion
Sesi 10 – Role of Lipid Management in ACS
Chairman: Sunarya Soerianata | Co-Chairman: Sunanto Ng
Panelist: Bambang Widyantoro, Ni Made Ayu Wulan, Al Fazir Omar, Pannipa Suwannasom
Panelist: Bambang Widyantoro, Ni Made Ayu Wulan, Al Fazir Omar, Pannipa Suwannasom
14.00 – 14.12
When PVCs Point to Trouble: A Case of Occlusion and High Lipoprotein(a)
Al Fazir Omar
14.12 – 14.24
The Statin Surge: Why Intensity Matters in Early ACS Management
Daniel PL Tobing
14.24 – 14.36
Role of Lp(a) in risk assessment of IHD
William Kristanto
14.36 – 14.48
New horizon opened: transformative role of Inclisiran in modern lipid management for post-ACS patients
Bambang Widyantoro
14.48 – 15.00
Discussion
Sesi 12 – The Link Between Cardiac Biomarkers and Invasive Revascularization in ACS
Chairman: Daniel PL Tobing | Co-Chairman: Irmalita
Panelist: Wong Shuin Woei, Hana Soraya
Panelist: Wong Shuin Woei, Hana Soraya
15.00 – 15.12
The Role of Hs Troponin in the management of ACS
Muhammad Fadil
15.12 – 15.24
Management dilemma acute heart failure patients with elevated cardiac enzymes
Vienna Rossimarina
15.24 – 15.36
Cardiac Enzyme Elevation in the ICU: Differentiating True Ischemia from Myocardial Injury
Wong Shuin Woei
15.36 – 15.48
NT-proBNP in Critically Ill Myocardial Infarction Patients
Indra Prasetya
15.48 – 16.00
Discussion
TBA Faculty Dinner
Saturday, 26 July 2025
Ballroom 1: STEMI Track
Sesi 13 – PPCI Surprises: Managing Unusual Cases in Acute Coronary Intervention
Chairman: Siska Suridanda Danny | Co-Chairman: Cheng-Hsueh Wu
Panelist: Yuji Ikari, Sidney Lo, Nur Haryono, Deanna Khoo
Panelist: Yuji Ikari, Sidney Lo, Nur Haryono, Deanna Khoo
09.00 – 09.12
How to treat AMI in a patient post TAVI?
Hung Chou Yang
09.12 – 09.24
Fatal Deception: Aortic Dissection with Coronary Occlusion—The Ultimate Management Dilemma
Chang Chia-Hsiu
09.24 – 09.36
SCAD in Focus: From Suspicion to Stabilization
Deanna Khoo
09.36 – 09.48
OCT Complication in STEMI
Pinakin Parekh
09.48 – 10.00
Discussion
Ballroom 2: NSTEMI Track
Sesi 14 – Acute Myocardial infarction complicating Cardiogenic shocks
Chairman: Daniel PL Tobing | Co-Chairman: Fahim Jafary
Panelist: Faisal Habib, Hendry Purnasidha Bagaswoto, Wong Shiun Woie, Vidya Gilang Rejeki
Panelist: Faisal Habib, Hendry Purnasidha Bagaswoto, Wong Shiun Woie, Vidya Gilang Rejeki
09.00 – 09.12
Risk Stratification in Acute Myocardial Infarction: Identifying Patients at Risk for Cardiogenic Shock
Faisal Habib
09.12 – 09.24
Management of Cardiogenic Shock from Pharmacology to Device Therapy
Hendry Purnasidha Bagaswoto
09.24 – 09.36
Cardiogenic Shock Management: Asia-Pacific Update
Michael Lee
09.36 – 09.48
The Evolving Landscape of Cardiogenic Shock: Evidence and Future Perspectives from IndONEsia ICCU & ACS registry
Vidya Gilang Rejeki
09.48 – 10.00
Discussion
10.00 – 11.00 AMI Jeopardy Competition (Exhibition Room)
Sesi 15 – Bioadaptive angioplasty in ACS and Beyond
Chairman: Teguh Santoso | Co-Chairman: Paul Ong
Panelist: Tam Li Wah, Sodiqur Rifqi, Patrick Lim
Panelist: Tam Li Wah, Sodiqur Rifqi, Patrick Lim
11.00 – 11.12
Singapore Results from the Infinity Swede Heart RCT
Paul Ong
11.12 – 11.24
One-year outcomes with the DynamX BioAdaptor on PPCI – SG experience
Ho Hee Hwa
11.24 – 11.36
Multicenter retrospective study on STEMI patients undergoing PPCI with the DynamX BioAdaptor – Hong Kong Experience
Chung Tak Shun
11.36 – 11.48
Beyond Revascularization: The Value of Trimetazidine in Post-Invasive Care
Doni Firman
11.48 – 12.00
Discussion
Sesi 17 – Late presenters STEMI
Chairman: Fazila Tun Nessa Malik | Co-Chairman: Sodiqur Rifqi
Panelist: Asri Ranga, Cheng Hsueh Wu, Joshua Loh, Yusra Pintaningrum
Panelist: Asri Ranga, Cheng Hsueh Wu, Joshua Loh, Yusra Pintaningrum
13.00 – 13.12
Cases of Late presenter of STEMI
Yusra Pintaningrum
13.12 – 13.24
The benefit of revascularization in Late presenter STEMI
Asri Ranga
13.24 – 13.36
Strategy to improve late presenter STEMI
Cheng Hsueh Wu
13.36 – 13.48
Mechanical Complications of Late Presenters of AMI
Joshua Loh
13.48 – 14.00
Discussion
Sesi 16 – Role of Mechanical Circulatory Support Devices
Chairman: Michael Lee | Co-Chairman: Faisal Habib
Panelist: Yu Chen Wang, Hendry Purnasidha B., Kwan Lee, Fazila Tun Nessa Malik
Panelist: Yu Chen Wang, Hendry Purnasidha B., Kwan Lee, Fazila Tun Nessa Malik
11.00 – 11.12
The difference in outcome between ACS and CCS patients undergoing Left Main PCI
Fazila Tun Nessa Malik
11.12 – 11.24
Latest Insights on Impella and ECMO for Infarct-Related Cardiogenic Shock: Evidence from DANGER-SHOCK & ECLS-SHOCK
Kwan Lee
11.24 – 11.36
From Shock to Recovery: Understanding Temporary Mechanical Circulatory Support
Aaron Wong
11.36 – 11.48
Pulsatile Circulatory Support in CHIP and Shock: A Clinical Role for iVAC 2L
Dafsah Arifa Juzar
11.48 – 12.00
Discussion
Sesi 18 – Personalised Management of NSTE – ACS
Chairman: Ismir Fahri | Co-Chairman: Miftah Pramudyo
Panelist: Thet Khaing, Goh Yew Seong, Hendy Wirawan
Panelist: Thet Khaing, Goh Yew Seong, Hendy Wirawan
13.00 – 13.12
Biomarker based Risk stratification in NSTE-ACS
Indah Sukmawati
13.12 – 13.24
Role of early invasive strategy in NSTE-ACS: Insights from Indonesia ICCU & ACS Registry
Akhtar Fajar Muzakkir
13.24 – 13.36
Timing for complete Revascularization in NSTE-ACS
Jusup Endang
13.36 – 13.48
Role of vulnerable plaque identification in NSTE-ACS
Nahar Taufiq
13.48 – 14.00
Discussion
14.00 – 15.00 Lunch and Exhibition
15.00 – 16.00 Closing Ceremony and Networking Session
Organised By
Co-organisers
